Draft NICE guidance on the management of atrial fibrillation has come under criticism for its recommendation around the use of apixaban or dabigatran as first choice options for anticoagulation. The guidance which closed for consultation this week also suggests that patients already taking other direct-acting oral anticoagulants or warfarin should be offered the option of...